Application note: New Peak Detection Using the SCIEX OS Software 1.5 MAM Workflow
Liquid chromatography mass spectrometry (LC-MS) is a highly accurate and sensitive platform used in biopharmaceutical research and development.
It provides unparalleled insight into many aspects of biotherapeutics which can be difficult to determine using other assays. In recent years, an LC-MS peptide mapping based multiple attribute method (MAM) has been used for characterization and monitoring of biologic quality attributes (PQAs) throughout development and manufacturing laboratories.
The MAM workflow enhances efficiency by replacing many conventional assays with one single method, which is not only capable of monitoring many PQAs simultaneously, but also potential impurities.
Related content from this organisation
- Application note: New Peak Detection Using the SCIEX OS Software 1.5 MAM Workflow
- Application note: Rapid Analysis of Genotoxic Nitrosamines by HPLC-MS/MS
- SCIEX Triple Quad™ 5500+ LC-MS/MS system – QTRAP® ready launches at ASMS 2019
- Application Note: Sensitive quantitation of the ADC ado-trastuzumab emtansine free cytotoxic drug DM1 in serum using MicroLC-MS
- Application Note: Highly selective bioanalytical quantitation method for analysis of R and S amlodipine enantiomers in human plasma using LC-MS/MS